GPCR - Wall Street Estimates - Structure Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 22.93

-3.45 %

$ 438 M

Market Cap

-9.8

P/E

Price Target Average

302.97%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

--115.97%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Structure Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for GPCR of $92.4 , with forecasts ranging from a low of $65 to a high of $118 .

GPCR Lowest Price Target Wall Street Target

65 USD 183.47%

GPCR Average Price Target Wall Street Target

92.4 USD 302.97%

GPCR Highest Price Target Wall Street Target

118 USD 414.61%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free